Blue Lizard Kids Sunscreen is a Topical Lotion in the Human Otc Drug category. It is labeled and distributed by Crown Laboratories. The primary component is Octocrylene; Zinc Oxide.
Product ID | 0316-2061_87aba532-a57f-3e27-e053-2a95a90ab3c3 |
NDC | 0316-2061 |
Product Type | Human Otc Drug |
Proprietary Name | Blue Lizard Kids Sunscreen |
Generic Name | Octocrylene And Zinc Oxide |
Dosage Form | Lotion |
Route of Administration | TOPICAL |
Marketing Start Date | 2019-01-02 |
Marketing Category | OTC MONOGRAPH NOT FINAL / OTC MONOGRAPH NOT FINAL |
Application Number | part352 |
Labeler Name | Crown Laboratories |
Substance Name | OCTOCRYLENE; ZINC OXIDE |
Active Ingredient Strength | 42 mg/mL; mg/mL |
NDC Exclude Flag | N |
Listing Certified Through | 2020-12-31 |
Marketing Start Date | 2019-01-02 |
NDC Exclude Flag | N |
Sample Package? | Y |
Marketing Category | OTC monograph not final |
Application Number | part352 |
Product Type | HUMAN OTC DRUG |
Marketing Start Date | 2019-01-02 |
Marketing Category | OTC monograph not final |
Application Number | part352 |
Product Type | HUMAN OTC DRUG |
Marketing Start Date | 2019-01-02 |
Marketing Category | OTC monograph not final |
Application Number | part352 |
Product Type | HUMAN OTC DRUG |
Marketing Start Date | 2019-01-02 |
Marketing Category | OTC monograph not final |
Application Number | part352 |
Product Type | HUMAN OTC DRUG |
Marketing Start Date | 2019-01-02 |
Marketing Category | OTC monograph not final |
Application Number | part352 |
Product Type | HUMAN OTC DRUG |
Marketing Start Date | 2019-01-02 |
Marketing Category | OTC monograph not final |
Application Number | part352 |
Product Type | HUMAN OTC DRUG |
Marketing Start Date | 2019-01-02 |
Ingredient | Strength |
---|---|
OCTOCRYLENE | 41.8 mg/mL |
NDC | Brand Name | Generic Name |
---|---|---|
0316-2061 | Blue Lizard Kids Sunscreen | Octocrylene and Zinc Oxide |
0316-2071 | Blue Lizard Active Sunscreen | Octocrylene and Zinc Oxide |
0316-2021 | Blue Lizard Sport Sunscreen | Octocrylene and Zinc Oxide |